The Effect of a Prehabilitation Exercise Program on Physical Functioning for Patients Undergoing Kidney Transplantation
Launched by UNIVERSITY OF BRITISH COLUMBIA · Aug 1, 2019
Trial Information
Current as of August 02, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special exercise program designed for patients who are about to undergo a kidney transplant. The goal is to see if doing exercises at home before the surgery can help improve physical strength, endurance, and overall well-being, which may lead to better recovery after the transplant. Researchers believe that patients who participate in this exercise program might experience fewer complications, shorter hospital stays, and an overall better recovery process.
To be eligible for this trial, participants need to be at least 19 years old, capable of doing the exercises, and able to read and write in English. They must also be receiving care at specific hospitals in Vancouver and have received medical approval for the transplant procedure. Those who join the study will be asked to follow the exercise program and complete some assessments to track their progress before and after the surgery. This trial is currently recruiting participants, so it’s an exciting opportunity for those who are preparing for a kidney transplant!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Ability to physically participate in a home-based prehabilitation program and all functional outcome measures
- • 2. Ability to read and write in English to respond to study questionnaires
- • 3. Age = to or \> 19 and any gender
- • 4. Receiving care at Vancouver General Hospital or St. Paul's Hospital
- • 5. Has been fully worked up for suitability for renal transplantation
- • 6. Received physician clearance to participate
- Exclusion Criteria:
- • 1. Unstable pulmonary or symptomatic cardiac disease
- • 2. Recent fracture or acute musculoskeletal injury that precludes the ability to exercise
- • 4. Is unable to understand the purpose of the study, or cannot give written consent
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Christopher Nguan, MD
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials